VEGF/VEGFR2 blockade does not cause retinal atrophy in AMD-relevant models

Intraocular injections of VEGF-neutralizing proteins provide tremendous benefits in patients with choroidal neovascularization (NV) due to age-related macular degeneration (AMD), but during treatment some patients develop retinal atrophy. Suggesting that VEGF is a survival factor for retinal neurons...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JCI Insight
Hlavní autoři: Long, Da, Kanan, Yogita, Shen, Jikui, Hackett, Sean F., Liu, Yuanyuan, Hafiz, Zibran, Khan, Mahmood, Lu, Lili, Campochiaro, Peter A.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012504/
https://ncbi.nlm.nih.gov/pubmed/29769445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.120231
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky